Market sentiment is not particularly positive these days, yet Johnson & Johnson continues to reward investors looking for safety and growth More
- ADVERTISEMENT
- ADVERTISEMENT
-
- Poll of the Day
- Partners
- ADVERTISEMENT
GILD
Recent Articles
Gilead Sciences, Inc. (GILD): Cheap Dividend Growth or Value Trap?
After a 23% decline, Gilead is drawing some attention. Buy GILD stock may not be something that dividend investors should buy on the dip. More
4 Cheap Dividend Growth Stocks to Buy (AVB, CMI, GILD, PSA)
I've used a very simple screening method to find these 4 dividend stocks that will grow earnings and payouts for long term investors More
7 Deeply Underloved Blue-Chip Stocks to Buy Now
These seven stocks to buy are big, familiar companies. You've seen their headlines ... now learn about their incredible value. More
There’s More to Johnson & Johnson (JNJ) Than Meets the Eye
Johnson & Johnson (JNJ) has an impressive pipeline most investors don't fully appreciate. This isn't your father's stock. More
Why Gilead Sciences, Inc. (GILD), Valeant Pharmaceuticals Intl Inc (VRX) and Core-Mark Holding Company, Inc. (CORE) Are 3 of Today’s Worst Stocks
Gilead (GILD), Valeant (VRX) and Core-Mark (CORE) were each suspiciously left out of Monday's rally effort. More
Gilead Sciences, Inc. (GILD) Investors Are Drowning in Negativity
Gilead Sciences (GILD) stock takes yet another hit as a rival comes after Gilead Sciences' lucrative HIV treatment market. More
